Wikipedia -WSS

Wikipedia

author：fashion 2025-09-04 05:36:40 - browse：96

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Google's generative AI to analyze medical images — and talk to docs

entertainment

WSS

Medicare drug price negotiation hasn't dried up venture capital

Election results set back Medicaid expansion plans

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

Medicare drug price negotiation hasn't dried up venture capital

Bristol Myers buys into radiopharmaceuticals with RayzeBio

SNAP should offer more nutrition education

entertainment

Wikipedia

leisure time

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Election results set back Medicaid expansion plans

Apple is now the first public company to be valued at $3 trillion

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Hepatitis C has a cure — but many Americans still lack access to it

Carvykti CAR

Heart attack and stroke risk calculators need revising

Google's generative AI to analyze medical images — and talk to docs

Duchenne breakthrough therapy leaves behind pioneering families

Christmas in the PICU brings some surprising joy

focus

What STAT readers think about the FDA and patient advocacy

Christmas in the PICU brings some surprising joy

Many breast cancer patients receive more radiation than needed

How to keep neuroscience’s past racism from being its future

Editas, Vertex strike deal on CRISPR

Readout Newsletter: The latest on Moderna, Apellis, and Merck

explore

entertainment

entertainment

leisure time